superpathway of tryptophan utilization

Pathway network for the superpathway of tryptophan utilization SuperPath

Sources:
  • PubChem
  • WikiPathways

Pathways in the superpathway of tryptophan utilization SuperPath

#NameSourceGenes
1superpathway of tryptophan utilizationPubChem
2Tryptophan metabolismWikiPathways
3tryptophan degradationPubChem
4L-kynurenine degradationPubChem
5NAD de novo biosynthesisPubChem
6L-tryptophan degradation XI (mammalian, via kynurenine)PubChem
7NAD de novo biosynthesis II (from tryptophan)PubChem
8L-tryptophan degradation III (eukaryotic)PubChem
9NAD biosynthesis II (from tryptophan)WikiPathways
10serotonin degradationPubChem
11tryptophan degradation to 2-amino-3-carboxymuconate semialdehydePubChem
12L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehydePubChem
13NAD biosynthesis from 2-amino-3-carboxymuconate semialdehydePubChem
14tryptophan degradation via tryptaminePubChem
152-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoAPubChem
16L-tryptophan degradation X (mammalian, via tryptamine)PubChem

Gene overlap in member pathways for superpathway of tryptophan utilization SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with superpathway of tryptophan utilization SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Congenital nad deficiency disorderEnrichmentHAAO, KYNU, NADSYN19.24
2Alpha-methylacetoacetic aciduriaEnrichmentACAT1, ACAT26.41
3Alcohol dependenceEnrichmentADH1B, ALDH25.47
4Alpha-aminoadipic and alpha-ketoadipic aciduriaEnrichmentDHTKD13.83
5Charcot-marie-tooth disease, axonal, type 2qEnrichmentDHTKD13.83
6Aromatic l-amino acid decarboxylase deficiencyEnrichmentDDC3.53
7Sjogren-larsson syndromeEnrichmentALDH3A23.53
8HydroxykynureninuriaEnrichmentKYNU3.43
9Vertebral, cardiac, renal, and limb defects syndrome 2EnrichmentKYNU3.43
10HypertryptophanemiaEnrichmentTDO23.43
11Vertebral, cardiac, renal, and limb defects syndrome 3EnrichmentNADSYN13.43
12Spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosisEnrichmentNMNAT13.43
13Brunner syndromeEnrichmentMAOA3.29
14Alcohol sensitivity, acuteEnrichmentALDH23.29
15Acetyl-coa acetyltransferase-2 deficiencyEnrichmentACAT23.18
16Vertebral, cardiac, renal, and limb defects syndrome 1EnrichmentHAAO3.13
17Catel-manzke syndromeEnrichmentKYNU3.13
18Leber congenital amaurosis 9EnrichmentNMNAT13.13
19Amed syndrome, digenicEnrichmentALDH22.99
20Developmental and epileptic encephalopathy 82EnrichmentGOT22.79
21Mitochondrial short-chain enoyl-coa hydratase 1 deficiencyEnrichmentECHS12.72
22DiarrheaEnrichmentNMNAT12.66
233-hydroxyacyl-coa dehydrogenase deficiencyEnrichmentHADH2.63
24AcatalasemiaEnrichmentCAT2.63
25Immunodeficiency 31aEnrichmentSTAT12.63
26Immunodeficiency 31bEnrichmentSTAT12.63
27Leukodystrophy, hypomyelinating, 2EnrichmentGCDH2.54
28Drug metabolism, poor, cyp2c19-relatedEnrichmentCYP2C192.50
29Brachycephaly, deafness, cataract, microstomia, and impaired intellectual developmentEnrichmentPOR2.50
30Letrozole toxicityEnrichmentCYP2A62.50
31Anemia, congenital dyserythropoietic, type ivaEnrichmentGCDH2.42
32Fetal hemoglobin quantitative trait locus 6EnrichmentGCDH2.42
33Ciliary dyskinesia, primary, 29EnrichmentGCDH2.42
34RasopathyEnrichmentDDC2.42
35Major affective disorder 1EnrichmentTPH22.33
36Dihydrolipoamide dehydrogenase deficiencyEnrichmentDLD2.33
37Striatonigral degeneration, infantileEnrichmentIL4I12.33
38Hyperinsulinemic hypoglycemia, familial, 4EnrichmentHADH2.33
39Methemoglobinemia due to deficiency of methemoglobin reductaseEnrichmentDLD2.33
40Immunodeficiency 31cEnrichmentSTAT12.33
41Glutaric acidemia iEnrichmentGCDH2.32
42Cerebral palsyEnrichmentALDH3A22.24
43Glaucoma 1, open angle, aEnrichmentCYP1B12.20
44Antley-bixler syndrome with genital anomalies and disordered steroidogenesisEnrichmentPOR2.20
45Anterior segment dysgenesis 6EnrichmentCYP1B12.20
46Antley-bixler syndrome without genital anomalies or disordered steroidogenesisEnrichmentPOR2.20
47Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiencyEnrichmentPOR2.20
48Cytochrome p450 oxidoreductase deficiencyEnrichmentPOR2.20
49Primary congenital glaucomaEnrichmentCYP1B12.20
50Hyperinsulinemic hypoglycemiaEnrichmentHADH2.15
51Cone dystrophyEnrichmentNMNAT12.05
52Coumarin resistanceEnrichmentCYP2A62.02
53Hereditary spastic paraplegia 56EnrichmentCYP2U12.02
54Spastic paraplegia 56, autosomal recessive, with or without pseudoxanthoma elasticumEnrichmentCYP2U12.02
55Major depressive disorderEnrichmentTPH21.93
56Glaucoma 3, primary infantile, bEnrichmentCYP1B11.90
57Tobacco addictionEnrichmentCYP2A61.90
58Hyperinsulinemic hypoglycemia, familial, 1EnrichmentHADH1.85
59Chronic mucocutaneous candidiasisEnrichmentSTAT11.85
60Nonsyndromic genetic hyperinsulinismEnrichmentHADH1.85
61Juvenile glaucomaEnrichmentCYP1B11.80
62Glaucoma, primary open angleEnrichmentCYP1B11.72
63Anterior segment dysgenesis 5EnrichmentCYP1B11.72
64Glaucoma 3, primary congenital, aEnrichmentCYP1B11.66
65Cone-rod dystrophy 2EnrichmentNMNAT11.61
66Lactic acidosisEnrichmentDLD1.55
67Developmental and epileptic encephalopathyEnrichmentGOT21.54
68Peters-plus syndromeEnrichmentCYP1B11.50
69Leber plus diseaseEnrichmentNMNAT11.46
70Lipoid congenital adrenal hyperplasiaEnrichmentPOR1.36
71Anterior segment dysgenesisEnrichmentCYP1B11.33
72Leigh syndrome, nuclearEnrichmentECHS11.19
73Leigh diseaseEnrichmentECHS11.15
74Lung cancerEnrichmentCYP2A61.01
75Hereditary retinal dystrophyEnrichmentNMNAT10.99
76Fundus dystrophyEnrichmentNMNAT10.99
77Hereditary spastic paraplegiaEnrichmentCYP2U10.90
78Primary ovarian insufficiencyEnrichmentPOR0.77
79Congenital nervous system abnormalityEnrichmentCYP2U10.54
80Nervous system diseaseEnrichmentCYP2U10.54

Loading...
Loading...
Loading...